RADNOR, Pa.--(BUSINESS WIRE)--The law firm of
Kessler Topaz Meltzer & Check, LLP
(www.ktmc.com) is currently investigating potential violations of the federal securities laws on behalf of investors of Hims & Hers Health, Inc.
(NYSE: HIMS) (“Hims & Hers”).
On June 23, 2025, during pre-market hours, the pharmaceutical company Novo Nordisk announced it would no longer provide Hims & Hers with direct access to its FDA-approved weight loss drug Wegovy through NovoCare Pharmacy due to concerns about illegal mass compounding and deceptive marketing by Hims & Hers. Specifically, Novo Nordisk explained that Hims & Hers allegedly failed to comply with laws prohibiting mass sales of compounded drugs and disseminated “deceptive marketing that put patient safety at risk."
On this news, Hims and Hers stock price fell over 20% during intraday trading on June 23, 2025.
If you are a Hims & Hers investor and would like to learn more about our investigation, please
CLICK HERE
to fill out our online form or contact Kessler Topaz Meltzer & Check, LLP: Jonathan Naji, Esq. (484) 270-1453 or E-mail at
info@ktmc.com
. You can also click on the following link or paste it in your browser:
https://ktmc.com/hims-hers-health-inc-investigation?utm_source=Businesswire&utm_medium=PR
Kessler Topaz Meltzer & Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer & Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars). For more information about
Kessler Topaz Meltzer & Check, LLP, please visit
www.ktmc.com.
May be considered attorney advertising in certain jurisdictions. Past results do not guarantee future outcomes.
